The cost of blood: Multidisciplinary consensus conference for a standard methodology

Transfusion Medicine Reviews

Volumn 19, Issue 1, 2005, Pages 66-78

  Shander, Aryeh ^a  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD ANALYSIS; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; CONSENSUS DEVELOPMENT; COST; ECONOMIC ASPECT; FOLLOW UP; FUTUROLOGY; HEALTH SERVICE; HUMAN; LONG TERM CARE; OUTCOMES RESEARCH; REVIEW; SCREENING TEST; STANDARDIZATION; TECHNIQUE; UNITED STATES;

EID: 13844264157     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.09.005     Document Type: Article

References (33)

1. L.N. Pealer, A.A. Marfin, and L.R. Petersen Transmission of West Nile virus through blood transfusion in the United States in 2002 N. Engl. J. Med. 349 2003 1236 1245
2. L.T. Goodnough, M.E. Brecher, and M.H. Kanter Transfusion medicine. First of two parts-blood transfusion N. Engl. J. Med. 340 1999 438 447
3. E.C. Vamvakas Epidemiology of red blood cell utilization Transfus. Med. Rev. 10 1996 44 61
4. K.C. Lowe, and E. Ferguson Benefit and risk perceptions in transfusion medicine: Blood and blood substitutes J. Intern. Med. 253 2003 498 507
5. J. Sprung, J.D. Kindscher, and J.A. Wahr The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: Results of a multicenter, randomized, single-blinded trial Anesth. Analg. 94 2002 799 808
6. G. Duffy, and K. Tolley Cost analysis of autologous blood transfusion, using cell salvage, compared with allogeneic blood transfusion Transfus. Med. 7 1997 189 196
7. L.T. Goodnough, T.G. Monk, and G. Sicard Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: An analysis of cost and benefit J. Vasc. Surg. 24 1996 213 218
8. D.L. Pittman Rationale for universal WBC reduction of blood components? Transfusion 40 2000 389
9. M. van Hulst, J.T. De Wolf, and U. Staginnus Pharmaco-economics of blood transfusion safety: Review of the available evidence Vox Sang. 83 2002 146 155
10. J.P. AuBuchon, C.A. Pickard, and L.H. Herschel Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: A Phase I clinical study Transfusion 42 2002 146 152
11. B.R. Jackson, J.P. AuBuchon, and M.P. Busch Cost-effectiveness of nucleic acid testing for HIV and HCV in donated blood Transfusion 40 2000 1385 (suppl.)
12. C. Goodman, S. Chan, and P. Collins Ensuring blood safety and availability in the US: Technological advances, costs, and challenges to payment-final report Transfusion 43 2003 3S 46S (suppl.)
13. Lewin Group Ensuring Blood Safety and Availability in the U.S.: Technological Advances, Costs, and Challenges to Payment. Final Report 2002 The Lewin Group Falls Church, VA 1 81
14. J.D. Birkmeyer, L.T. Goodnough, and J.P. AuBuchon The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement Transfusion 33 1993 544 551
15. J. Etchason, L. Petz, and E. Keeler The cost effectiveness of preoperative autologous blood donations N. Engl. J. Med. 332 1995 719 724
16. A. Pereira Cost-effectiveness analysis and the selection of blood products Curr. Opin. Hematol. 7 2000 420 425
17. K.A. Schulman, and B.P. Linas Pharmacoeconomics: State of the art in 1997 Annu. Rev. Public Health 18 1997 529 548
18. M.F. Drummond, G.L. Stoddart, and G.W. Torrance Cost Analysis, Methods for the Economic Evaluation of Health Care Programmes 1987 Oxford University Press New York 39 70
19. J.L. Callum, P.H. Pinkerton, and A.S. Coovadia An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients Transfusion 40 2000 1169 1175
20. S.B. Cantor, D.V. Hudson Jr., and B. Lichtiger Costs of blood transfusion: A process-flow analysis J. Clin. Oncol. 16 1998 2364 2370
21. P.Y. Crémieux, B. Barrett, and K. Anderson Cost of outpatient blood transfusion in cancer patients J. Clin. Oncol. 18 2000 2755 2761
22. Food and Drug Administration HHS Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule Fed. Regist. 66 2001 31146 31165
23. J.M. Forbes, M.D. Anderson, and G.F. Anderson Blood transfusion costs: A multicenter study Transfusion 31 1991 318 323
24. L.C. Jefferies, B.S. Sachais, and D.S. Young Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995 Transfusion 41 2001 522 529
25. A. Ortega, G. Dranitsaris, and A. Puodziunas A clinical and economic evaluation of red blood cell transfusions in patients receiving cancer chemotherapy Int. J. Technol. Assess. Health Care 14 1998 788 798
26. E.L. Wallace Blood services costs and charges Transfusion 41 2001 437 439
27. Custer BS: Community blood supply model: A new model for assessing the safety and sufficiency of the blood supply [thesis dissertation]. Seattle, WA, University of Washington, 2003
28. B.R. Jackson, M.P. Busch, and S.L. Stramer The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Transfusion 43 2003 721 729
29. R.E. Park, A. Fink, and R.H. Brook Physician ratings of appropriate indications for six medical and surgical procedures Am. J. Public Health 76 1986 766 772
30. D.A. Lubarsky, C. Hahn, and D.H. Bennett The hospital cost (fiscal year 1991/1992) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University Anesth. Analg. 79 1994 629 637
31. S.J. Varney, and J.F. Guest The annual cost of blood transfusions in the UK Transfus. Med. 13 2003 205 218
32. R. Tretiak, A. Laupacis, and M. Riviere Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group CMAJ 154 1996 1501 1508
33. M.J. Asadi, and W.A. Baltz Activity-based costing for clinical paths. An example to improve clinical cost and efficiency J. Soc. Health Syst. 5 1996 1 7